Medworxx Solutions Inc. Announces Results of Annual General and Special Meeting Held on June 26, 2013
Medworxx Solutions Inc. (the “Company” or “Medworxx”,
TSXV: “MWX”) is pleased to announce the successful completion of
its annual general and special meeting held on June 26, 2013 (the “Meeting”).
The Company had 45.31% of its issued and outstanding common shares
represented at the Meeting either in person or by proxy. At the Meeting,
shareholders voted to ratify certain amendments to the Company’s by-laws
to require advance notice for the nomination of directors, and also
approved the re-appointment of PriceWaterhouseCoopers LLP as auditors of
the Company for the ensuing year. In addition, shareholders appointed
the following directors to the board of directors of the Company to hold
office until the next annual shareholder’s meeting or until a successor
is elected: Bernard Webber, Renah Persofsky, Barry Tissenbaum, Sam
Marafioti, George Elliott, Paul Collins, Dan Matlow, and Joseph Lee
Matheson.
Joseph Lee Matheson is a newly appointed member of the board of
directors. Mr. Matheson is a co-founder of Broadview Capital Management
Inc., an investment management firm that invests in inefficiently-priced
North American securities. Broadview Capital Management, through the
Broadview Dark Horse LP, is a shareholder of Medworxx. Prior to founding
Broadview, Mr. Matheson was a securities analyst with KJ Harrison &
Partners from 2006 to 2008 and a securities analyst with AIC Investment
Services from 2003 to 2006. Mr. Matheson is also a member of the board
of directors at RDM Corp. (RC:TSX). Mr. Matheson holds the Canadian
Investment Manager (CIM) and Chartered Financial Analyst designations.
“Lee is a strong addition to the Medworxx board,” said Dan Matlow,
President & CEO, Medworxx. “We believe his wealth of equity market
contacts and experience is a positive step toward building shareholder
value, as we continue to grow our business.”
The Company is also announcing that it has retained Capital Ideas
Investor Relations (“CIIR”) to provide certain strategic investor
relations and communications services to the Company. CIIR has been
engaged for an initial term of six months, continuing on a month to
month basis thereafter. The Company will pay compensation of $5,000
(plus HST) per month and grant to CIIR 100,000 options, each option
entitling the holder to acquire one common share of the Company at an
exercise price of $0.34 per share for a term of one year. One quarter of
the options so granted will vest every three months following the date
of grant.
About Medworxx
Medworxx delivers health information technology solutions to over 350
hospitals internationally; including Canada, United States and United
Kingdom. Medworxx helps hospitals meet patient flow challenges, and
requirements in compliance and education. Medworxx Clinical
Criteria—flagship of Medworxx Patient Flow that includes electronic bed
board and independent assessment components—currently serves 33%of the
acute care beds in Canada. Visit: www.medworxx.com.
About Capital Ideas Investor Relations
Based in Toronto, Ontario, CIIR carries on the business of investor
relations services including assisting public companies with the
production and dissemination of information materials to the investment
community and managing shareholder inquiries.
Disclaimers: The statements made in this press
release may contain forward-looking statements that involve a number of
risks and uncertainties. Actual events or results could differ
materially from the Company’s expectations and projections.
Forward-looking statements involve known and unknown risks,
uncertainties and other factors, such as competition, technological
changes, the changing needs of hospitals, the financial condition of the
Company’s current and potential customers, foreign currency exchange
rates, as well as general economic conditions, which may cause the
actual results, performance or achievements of the Company to be
materially different from any future results, performance or
achievements expressed or implied by the forward-looking statements. The
Company is under no obligation to update forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation Services Provider
(as that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this released.
Copyright Business Wire 2013